Posted on 11/6/20
Entasis Therapeutics Provides a Business Update
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel . . .
Posted on 11/6/20
Caladrius Biosciences Provides Corporate Update
BASKING RIDGE, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 11/6/20
Sarepta Therapeutics Announces Recent Corporate Developments
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for . . .
Posted on 11/6/20
CorMedix Provides Business Update
BERKELEY HEIGHTS, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the . . .
Posted on 11/6/20
Ziopharm Oncology Provides Corporate Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced its financial results for the third quarter ended September 30, 2020 and . . .
Posted on 11/6/20
Celldex Provides Corporate Update
HAMPTON, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2020. . . .
Posted on 11/6/20
Molecular Templates Provides a Corporate Update
AUSTIN, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted . . .
Posted on 11/6/20
Adicet Provides Business Update
MENLO PARK, Calif. and BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta . . .
Posted on 11/6/20
Coronavirus Recap, Oct. 29 – Nov. 5: As Positivity Rates Rise, Local Leaders Look to Reinstate Restrictions
Maryland reported an additional 1,198 coronavirus cases on Thursday, the largest amount since the state’s caseload grew by 1,288 on July 25.This is also the second . . .
Posted on 11/5/20
Chimerix Misses Q3 Estimates by a Penny
Biopharmaceutical company Chimerix missed earnings estimates slightly with a third-quarter net loss of 18 cents per basic and diluted share, up from a loss of $1.26 . . .
Posted on 11/5/20
MD NOW Expands to Southwest Florida
Largest urgent care provider opens 4 clinics in the Fort Myers, Cape Coral and Bradenton markets over the past monthNew M.D. Now Location in Ft. MyersMD . . .
Posted on 11/5/20
BD Announces Fiscal Fourth Quarter And Full Year 2020 Results
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended . . .
Posted on 11/5/20
Cigna Reports Third Quarter 2020 Performance
Global health services company Cigna Corporation (NYSE: CI) today reported solid third quarter 2020 performance led by strong execution by its Evernorth segment."In these dynamic and . . .
Posted on 11/5/20
Akebia Reports Third Quarter 2020 Financial Results
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for . . .
Posted on 11/5/20
Stealth BioTherapeutics Reports Third Quarter 2020 Financial Results
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today reported . . .
Posted on 11/5/20
U.S. Physical Therapy Reports Record Quarterly Earnings
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported record results . . .
Posted on 11/5/20
AmerisourceBergen Reports Fiscal 2020 Fourth Quarter and Year End Results
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2020 fourth quarter ended September 30, 2020, revenue increased 7.9 percent to $49.2 . . .
Posted on 11/5/20
Merrimack Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced its third quarter 2020 financial results for the period ended September 30, 2020.“We are pleased that both . . .
Posted on 11/5/20
Alnylam Pharmaceuticals Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2020 and reviewed recent . . .
Posted on 11/5/20
Magenta Therapeutics Reports Recent Business Highlights and Third Quarter Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today reported . . .
Posted on 11/5/20
Aldeyra Therapeutics Announces Third-Quarter 2020 Financial Results and Provides Corporate Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives . . .
Posted on 11/5/20
AVROBIO Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today reported . . .
Posted on 11/5/20
Diversified Healthcare Trust Announces Third Quarter 2020 Results
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter and nine months ended September 30, 2020."While the senior living industry . . .
Posted on 11/5/20
Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported . . .
Posted on 11/5/20
Bicycle Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, England, & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycles®) . . .

